Published in Biotech Business Week, March 28th, 2005
Geraghty is senior vice president of Genzyme Corporation and head of its cardiovascular business. At Genzyme, he was previously Senior Vice President of International Development and President of Genzyme Europe. He is a founder, former chairman, and member of the board of GTC Biotherapeutics.
"Jim Geraghty is a respected pharmaceutical executive with experience developing global markets for high-value products in specialized indications, similar to GENETIX' lead product LentiGlobin hemoglobin gene therapy for sickle cell disease and thalassemia...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.